Expanding Medication-Assisted Therapies in Central Asia
Recruiting now · Not applicable
Conditions studied: Opioid Use Disorder
In brief
Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy to scale-up OAT in three diverse Central Asian countries (Kazakhstan, Kyrgyzstan, Tajikistan) and guided by the Exploration-Planning-Implementation-Sustainment (EPIS) framework. Understanding the trajectories of implementation and scale-up in this context may emerge through creating communities of practice, especially when cohesion and competence evolves, and may guide other healthcare delivery challenges in the region (e.g., HIV, TB); as well as build important regional expertise and understanding implementation trajectories should help support OAT program sustainability.
Key facts
- Study ID
- NCT05579470
- Run by
- Yale University
- People needed
- 900
- Starts
- 2023-08-07
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-09-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- i. Aim 1: The inclusion criteria for Aim 1 Consists of:
- Quantitative surveys for PWID
- 18 years or older
- Meeting DSM-V criteria for opioid dependence
- Be either treatment naïve and seeking OAT or be on OAT for < 90 days
- Organizational Assessments for OAT Delivery Staff
- 18 years or older
- Currently working as an OAT delivery professional at an OAT delivery site
- Focus Groups (PWID on OAT)
- 18 years or older
- Meeting DSM-V criteria for opioid dependence
- Be either treatment naïve and seeking OAT or be on OAT for < 90 days
- Focus Groups (PWID not on OAT)
- 18 years or older
- Meeting Diagnostic and Statistical Manual of Mental Disorders(DSM)-V criteria for opioid dependence
- Be OAT naïve (defined as never having been on OAT or having not received treatment for > 1 year)
- Focus Groups (OAT delivery staff)
- 18 years or older
- Currently working as an OAT delivery professional at an OAT delivery site
- ii. Aim 2: The inclusion criteria for Aim 2 consists of:
- 18 years or older
- Currently assigned as a Chief Narcologist for an Oblast
- iii. Aim 3: The inclusion criteria for Aim 3 consists of:
- 18 years or older
- Authorized as a professional to work at an OAT delivery site
You may not qualify if…
- Not willing to provide consent
Where it is running
- Columbia University Global Health Research Center of Central Asia — Almaty, Kazakhstan (enrolling)
- Den Sooluk Nuru — Bishkek, Kyrgyzstan (enrolling)
- Institute for International Health and Education — Dushanbe, Tajikistan (enrolling)
- Yale University — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.